At a glance
ClinicalIndex Comparison RecordN/ACompleted· 170 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Prevalence of Metabolic Syndrome in Patients With Intermittent Claudication
In Brief
An observational study for Intermittent Claudication and Metabolic Syndrome X. Completed, enrolled 170 participants across 1 site.
Detailed Summary
Metabolic syndrome, a group of cardiovascular risk factors related to insulin resistance, is a major determinant of cardiovascular mortality. Intermittent claudication is a symptom of an early stage of atherosclerosis. The aim of this study is to determine the prevalence of the metabolic syndrome in patients with intermittent claudication and its correlation with age, gender, localization of arterial obstruction and association with coronary artery disease.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsIntermittent Claudication, Metabolic Syndrome X
CountriesBrazil
Collaborators--
Timeline
N/ACompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
Enrollment StartMay 2009
Primary CompletionJul 2009
First PostedJul 2009
TodayJul 2026
First PostedJul 27, 2009
Enrollment StartMay 1, 2009
Primary CompletionJul 1, 2009
TodayJul 2, 2026
Enrollment to primary: 2 monthsPosted 16.9 years ago